Overview

Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD

Status:
Completed
Trial end date:
2015-04-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alcohol during birth.
Phase:
Phase 1
Details
Lead Sponsor:
University of Oklahoma
Collaborators:
Eli Lilly and Company
Mark L. Wolraich, M.D.
Treatments:
Atomoxetine Hydrochloride
Ethanol